Business Context and Reporting Period
Company: Marchex, Inc. (MCHX)
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2026
Reporting Period: Event date of February 17, 2026
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and executive compensation rather than financial performance.
Material Changes
The primary material change reported is the approval of new equity compensation grants for three senior executives under the 2021 Stock Incentive Plan. No changes to financial position or operational metrics are disclosed in this document.
Guidance, Outlook, and Management Commentary
Executive Compensation Grants: On February 17, 2026, the Compensation Committee approved the following Restricted Stock Unit (RSU) grants, vesting in full on the first anniversary of the grant date:
- Troy Hartless (President & Chief Revenue Officer): 128,205 RSUs
- Francis Feeney (Chief Operating Officer, Chief Legal Officer, & Corporate Secretary): 96,153 RSUs
- Brian Nagle (Chief Financial Officer): 56,089 RSUs
Risks and Contingencies: The filing text does not provide a clear value or specific disclosure regarding new risks, contingencies, or unusual items beyond the standard equity grant terms.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2021 Stock Incentive Plan to assess remaining capacity for future grants.
- Confirm the current trading price of Class B Common Stock (MCHX) to calculate the fair market value of the granted RSUs.
- Review the vesting schedule details to ensure the "full vesting on first anniversary" term aligns with standard retention practices for the company.
- Check for any subsequent filings regarding the departure or appointment of the named officers.